001     289801
005     20240428010954.0
024 7 _ |a 10.1073/pnas.2313971121
|2 doi
024 7 _ |a pmid:38662573
|2 pmid
024 7 _ |a 0027-8424
|2 ISSN
024 7 _ |a 1091-6490
|2 ISSN
024 7 _ |a altmetric:162854765
|2 altmetric
037 _ _ |a DKFZ-2024-00880
041 _ _ |a English
082 _ _ |a 500
100 1 _ |a Bosch, Thomas C G
|0 0000-0002-9488-5545
|b 0
245 _ _ |a The potential importance of the built-environment microbiome and its impact on human health.
260 _ _ |a Washington, DC
|c 2024
|b National Acad. of Sciences
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1714138231_27237
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a There is increasing evidence that interactions between microbes and their hosts not only play a role in determining health and disease but also in emotions, thought, and behavior. Built environments greatly influence microbiome exposures because of their built-in highly specific microbiomes coproduced with myriad metaorganisms including humans, pets, plants, rodents, and insects. Seemingly static built structures host complex ecologies of microorganisms that are only starting to be mapped. These microbial ecologies of built environments are directly and interdependently affected by social, spatial, and technological norms. Advances in technology have made these organisms visible and forced the scientific community and architects to rethink gene-environment and microbe interactions respectively. Thus, built environment design must consider the microbiome, and research involving host-microbiome interaction must consider the built-environment. This paradigm shift becomes increasingly important as evidence grows that contemporary built environments are steadily reducing the microbial diversity essential for human health, well-being, and resilience while accelerating the symptoms of human chronic diseases including environmental allergies, and other more life-altering diseases. New models of design are required to balance maximizing exposure to microbial diversity while minimizing exposure to human-associated diseases. Sustained trans-disciplinary research across time (evolutionary, historical, and generational) and space (cultural and geographical) is needed to develop experimental design protocols that address multigenerational multispecies health and health equity in built environments.
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Anthropocene
|2 Other
650 _ 7 |a architectural design
|2 Other
650 _ 7 |a evolution
|2 Other
650 _ 7 |a metaorganism
|2 Other
650 _ 7 |a microbiome
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Built Environment
|2 MeSH
650 _ 2 |a Microbiota: physiology
|2 MeSH
650 _ 2 |a Animals
|2 MeSH
700 1 _ |a Wigley, Mark
|0 0009-0003-8942-479X
|b 1
700 1 _ |a Colomina, Beatriz
|0 0009-0009-6526-9338
|b 2
700 1 _ |a Bohannan, Brendan
|b 3
700 1 _ |a Meggers, Forrest
|0 0000-0002-9037-7578
|b 4
700 1 _ |a Amato, Katherine R
|0 0000-0003-2722-9414
|b 5
700 1 _ |a Azad, Meghan B
|0 0000-0002-5942-4444
|b 6
700 1 _ |a Blaser, Martin J
|0 0000-0003-2447-2443
|b 7
700 1 _ |a Brown, Kate
|b 8
700 1 _ |a Dominguez-Bello, Maria Gloria
|0 0000-0002-8879-6159
|b 9
700 1 _ |a Ehrlich, Stanislav Dusko
|b 10
700 1 _ |a Elinav, Eran
|0 P:(DE-He78)725ad944da4e1ea60389fe9dbbed2c7c
|b 11
|u dkfz
700 1 _ |a Finlay, B Brett
|0 0000-0001-5303-6128
|b 12
700 1 _ |a Geddie, Kate
|0 0000-0003-3629-1949
|b 13
700 1 _ |a Geva-Zatorsky, Naama
|0 0000-0002-7303-854X
|b 14
700 1 _ |a Giles-Vernick, Tamara
|0 0000-0003-2873-8544
|b 15
700 1 _ |a Gros, Philippe
|0 0000-0002-0114-1978
|b 16
700 1 _ |a Guillemin, Karen
|0 0000-0001-6004-9955
|b 17
700 1 _ |a Haraoui, Louis-Patrick
|0 0000-0002-3713-7866
|b 18
700 1 _ |a Johnson, Elizabeth
|0 0000-0002-8290-1122
|b 19
700 1 _ |a Keck, Frédéric
|0 0000-0002-7711-7288
|b 20
700 1 _ |a Lorimer, Jamie
|0 0000-0003-4369-0884
|b 21
700 1 _ |a McFall-Ngai, Margaret J
|0 0000-0002-6046-6238
|b 22
700 1 _ |a Nichter, Mark
|0 0000-0002-4112-3010
|b 23
700 1 _ |a Pettersson, Sven
|0 0000-0001-8903-3738
|b 24
700 1 _ |a Poinar, Hendrik
|0 0000-0002-0314-4160
|b 25
700 1 _ |a Rees, Tobias
|0 0000-0002-8273-7393
|b 26
700 1 _ |a Tropini, Carolina
|0 0000-0002-7542-1577
|b 27
700 1 _ |a Undurraga, Eduardo A
|0 0000-0002-4425-1253
|b 28
700 1 _ |a Zhao, Liping
|b 29
700 1 _ |a Melby, Melissa K
|0 0000-0003-1766-5466
|b 30
773 _ _ |a 10.1073/pnas.2313971121
|g Vol. 121, no. 20, p. e2313971121
|0 PERI:(DE-600)1461794-8
|n 20
|p e2313971121
|t Proceedings of the National Academy of Sciences of the United States of America
|v 121
|y 2024
|x 0027-8424
909 C O |o oai:inrepo02.dkfz.de:289801
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)725ad944da4e1ea60389fe9dbbed2c7c
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2024
915 _ _ |a National-Konsortium
|0 StatID:(DE-HGF)0430
|2 StatID
|d 2023-08-26
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b P NATL ACAD SCI USA : 2022
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-08-26
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-26
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
|d 2023-08-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-26
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b P NATL ACAD SCI USA : 2022
|d 2023-08-26
920 1 _ |0 I:(DE-He78)D480-20160331
|k D480
|l Mikrobiom und Krebs
|x 0
920 1 _ |0 I:(DE-He78)F220-20160331
|k F220
|l Mikrobiom und Krebs
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D480-20160331
980 _ _ |a I:(DE-He78)F220-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21